The latest report by IMARC Group, titled “ Report by Type (Blood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, and Others), End User (Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the market.
Diabetes Care Devices Market Trends
The global diabetes care devices market size reached US$ 32.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 59.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.
Factors Affecting the Growth of the Diabetes Care Devices Industry:
- Increasing Prevalence of Diabetes:
The surge in diabetes prevalence acts as a primary catalyst for the expansion of the diabetes care devices sector. Currently, millions suffer from this chronic condition, necessitating rigorous and continuous management to prevent severe complications. Additionally, the rising number is escalating the demand for diabetes care devices such as glucose meters, insulin pumps, and continuous glucose monitoring systems (CGMs). As diabetes becomes more widespread, the imperative for effective management tools becomes paramount, enhancing the quality of life for individuals and reducing the long-term healthcare costs associated with diabetes-related complications. The devices help in precise monitoring and management, making daily care more manageable and improving overall patient outcomes.
- Technological Advancements in Diabetes Care Devices:
Technological innovations are significantly shaping the diabetes care devices industry. Additionally, recent advancements have led to the development of more accurate, efficient, and user-friendly devices that substantially enhance diabetes management. Moreover, continuous Glucose Monitoring (CGM) systems provide real-time insights into glucose levels, allowing for immediate adjustments in therapy, which is a vast improvement over traditional blood glucose meters. Furthermore, the advent of closed-loop insulin delivery systems, or artificial pancreas, marks a revolutionary step in diabetes care. These systems automatically adjust insulin delivery based on CGM data, minimizing the risk of hypo- and hyperglycemia and making diabetes management less burdensome for patients.
- Increasing Healthcare Expenditure
Healthcare expenditure is on the rise, particularly in emerging economies where economic growth is enabling greater access to healthcare services. Additionally, the increased spending is crucial in the context of diabetes care, as it improves access to advanced healthcare solutions and diabetes management devices. In countries such as China and India, rapidly growing healthcare budgets are making diabetes care devices more accessible to a larger segment of the population. Furthermore, investments in healthcare infrastructure and services are expanding the reach of modern medical care, thereby supporting the diabetes care devices industry. As more individuals gain access to these advanced diabetes management tools, it directly contributes to the growth and expansion of the diabetes care devices market, enhancing overall public health outcomes.
For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/diabetes-care-devices-market/requestsample
Competitive Landscape:
The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.
- Abbott Laboratories
- ACON Laboratories Inc.
- Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
- Becton Dickinson and Company
- Bionime Corporation
- Dexcom Inc.
- F. Hoffmann-La Roche AG
- Johnson & Johnson
- Medtronic plc
- Novo Nordisk A/S
- Sinocare Inc.
- Terumo Corporation
Diabetes Care Devices Market Report Segmentation:
By Type:
- Blood Glucose Monitoring (BGM) Devices
- Self-Monitoring Devices
- Continuous Glucose Monitoring Devices
- Insulin Delivery Devices
- Pumps
- Pens
- Syringes
- Jet Injectors
Blood glucose monitoring (BGM) devices hold the largest market share due to the rising prevalence of diabetes worldwide and the increasing demand for convenient and accurate blood glucose monitoring solutions.
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Diabetes Clinics/Centers
- Online Pharmacies
- Others
Hospital pharmacies represent the largest segment as hospitals tend to have a higher volume of patients with diabetes who require continuous access to diabetes care devices and supplies.
By End User:
- Hospitals
- Homecare
- Diagnostic Centers
- Ambulatory Surgery Centers
Hospitals dominate the market, as they serve as primary centers for managing diabetes-related complications and treatments, necessitating a wide range of diabetes care devices and resources.
Regional Insight:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America’s dominance in the diabetes care devices market is attributed to the growing awareness about diabetes management, advanced healthcare infrastructure, and a significant diabetic population demanding sophisticated diabetes care devices.
Global Diabetes Care Devices Market Trends:
At present, non-invasive or minimally invasive glucose monitoring technologies are being developed as an alternative to traditional fingerstick testing. These technologies utilize methods such as transdermal sensing, optical coherence tomography, and spectroscopy to measure glucose levels without the need for blood samples. There is a growing trend toward smaller, more discreet, and wearable devices for diabetes management. Moreover, miniaturized CGM systems, insulin pumps, and patch pumps offer greater convenience and improved adherence to therapy regimens. Wearable insulin delivery systems, such as insulin patches or smart insulin pens, are also gaining traction.
Ask Analsyt for Customization: https://www.imarcgroup.com/request?type=report&id=5746&flag=C
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
